Fenbufen is an analgesic, antipyretic and anti-inflammatory drug that is ch
aracterized by poor water solubility, a defect increased by very low wettab
ility. Poor water solubility, particularly at low pH, could decrease absorp
tion in the upper part of the gastrointestinal tract, which would be inconv
enient for good bioavailability. Different spherical crystallization proces
ses have been considered as methods to improve fenbufen dissolution behavio
r. A two-solvent system, in the presence of a bridging liquid, is the only
method capable of producing spherical fenbufen crystals. In a first step, f
enbufen solubility was considered in different solvents. The drug crystals
formed were typically needle shaped. This characteristic was considered as
a favorable parameter to obtain spherical crystals. After the selection of
the best fenbufen solvent, several ratios of solvent (S)-nonsolvent (NS) (t
etrahydrofuran [THF]-demineralized water) were studied. The addition of a b
ridging liquid (isopropyl acetate) improved spherical crystallization. The
results from this method were reproducible batch to batch. The spherical cr
ystals obtained showed a clear improvement in dissolution capacity, probabl
y due to better wettability. Dissolution studies were then carried out on t
hese spherical crystals stored for 1 month at different relative humidities
(RHs). The dissolution profiles remained unchanged.